Browsing by Subject "A61K 35/28"
Now showing items 1-13 of 13
-
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-10-23)The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
-
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-06-23)The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
-
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-07-22)The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
-
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-17)The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
-
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-08-15)The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-12-06)The present invention encompasses an osteogenic composition comprising mesenchymal stem cells pre-cultured in the presence of an agent that accelerates canonical Wnt signaling therein. Also, provided are osteogenic ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-09-27)Materials and methods for preparing mesenchymal stem cells are described such that the mesenchymal stem cells remain for a longer period of time than would normally be found at a site of tissue healing. The mesenchymal ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-07-16)"A method of producing mesenchymal stem cells from induced pluripotent stem cells in which induced pluripotent stem cells are cultured in the presence of a TGF-β inhibitor an in an atmosphere containing from about 7 vol. ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-01-26)Aspects of the invention are directed to mineral-based nanoparticles comprising silicate nanoparticles that induce human mesenchymal stem cells (hMSCs) into a cartilage-lineage through the upregulation of cartilage-specific ...
-
Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-06-24)The present invention encompasses methods, compositions, and devices for treating an ocular disease, disorder or condition in a mammal. The invention includes polypeptides that possess anti-inflammatory, anti-apoptotic, ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-07-28)The present invention encompasses methods, compositions, and devices for treating an ocular disease, disorder or condition in a mammal. The invention includes polypeptides that possess anti-inflammatory, anti-apoptotic, ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-11-02)Preparations comprising an enriched population of extracellular vesicles (nEVs) having a negatively charged surface, and that are CD81+ and CD9-, are provided. Improved processes and methods for producing an enriched ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-11-22)The present invention encompasses methods, compositions, and devices for treating an ocular disease, disorder or condition in a mammal. The invention includes polypeptides that possess anti-inflammatory, anti-apoptotic, ...